Mittelmeier ceramic total hip arthroplasty. A retrospective study

Area of Science:

• Biomaterials Science
• Orthopedic Surgery
• Medical Device Engineering

Background:

• Ceramics offer low reactivity and high durability, making them suitable for biologic implants.
• Total hip arthroplasty (THA) is a common procedure to address hip joint issues.
• Aseptic loosening is a primary cause of failure in hip prostheses.

Purpose of the Study:

• To evaluate the clinical performance and long-term durability of the Mittelmeier ceramic total hip prosthesis.
• To identify factors influencing the success and failure rates of ceramic hip implants.
• To assess the biocompatibility of ceramic materials in THA.

Main Methods:

• A retrospective study of 62 patients (69 hips) who received the Mittelmeier ceramic total hip prosthesis.
• Average follow-up of 37.6 months.
• Analysis of revision rates due to aseptic loosening and correlation with femoral interference fit.

Main Results:

• 19 cases (27%) required revision surgery, primarily due to aseptic loosening.
• The average time to revision was 26.2 months.
• A proper femoral interference fit (90% intramedullary canal fill) was linked to better clinical outcomes, reduced radiolucencies, and fewer aseptic loosening failures.
• No adverse effects related to the ceramic biomaterial were observed.

Conclusions:

• The Mittelmeier ceramic total hip prosthesis demonstrates biocompatibility but faces challenges with aseptic loosening.
• Optimizing femoral interference fit is crucial for enhancing fixation and improving the long-term durability of ceramic hip implants.
• Further design modifications may be necessary to achieve superior fixation and reduce revision rates.